ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Operating margin 2016–2024
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) operating margin by fiscal year — reported operating income divided by reported revenue.
-38.6%FY2024 · since FY2016: -512.7% → -38.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -38.6% | +193.2 pp |
| FY2023 | -231.8% | +372.2 pp |
| FY2022 | -604.0% | +2034.6 pp |
| FY2021 | -2638.6% | +731.9 pp |
| FY2020 | -3370.5% | +9086.7 pp |
| FY2019 | -12457.2% | -12318.8 pp |
| FY2018 | -138.4% | +74.8 pp |
| FY2017 | -213.2% | +299.5 pp |
| FY2016 | -512.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ADAPY financial trends
ADAPY RevenueADAPY Net incomeADAPY Net marginADAPY Gross profitADAPY Gross marginADAPY Operating incomeADAPY Operating cash flowADAPY Free cash flowADAPY Capital expendituresADAPY Return on equityADAPY Stock buybacksADAPY Dividends paidADAPY Total assetsADAPY Total liabilitiesADAPY Shareholders’ equityADAPY overview →